Basso Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Basso Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-65,082	Closed	-$373K	–	145
2015 Q2	$418K	Sell	65,082 -10,000	-13%	-$67K	0.06%	90
2015 Q1	$528K	Buy	75,082 +40,000	+114%	+$290K	0.08%	90
2014 Q4	$270K	Hold	35,082	–	–	0.04%	103
2014 Q3	$262K	Hold	35,082	–	–	0.04%	93
2014 Q2	$340K	Sell	35,082 -324,590	-90%	-$2.89M	0.06%	84
2014 Q1	$2.99M	Buy	+359,672	New	+$3.08M	0.55%	46

Other funds holding PDLI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Basso Capital Management's PDLI Position: Q3 2015 in Review

Basso Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2015, closing a stake of 65,082 shares — an estimated $373K sold.

Basso Capital Management first reported a position in PDLI in Q1 2014 and held it in 6 quarters. The position peaked at $2.99M in Q1 2014. 213 funds tracked by Wall St. Rank hold PDLI as of Q3 2015.

Basso Capital Management reported no remaining PDL BioPharma, Inc. position as of Q3 2015 after selling out during the quarter.
Basso Capital Management sold 65,082 PDL BioPharma, Inc. shares in Q3 2015, an estimated $373K.
Basso Capital Management first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 6 quarters.
Basso Capital Management's PDL BioPharma, Inc. position peaked at $2.99M in Q1 2014.
213 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2015.

Based on Basso Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.